NIH-funded research NIH-funded research

A tool to help collect biomarkers remotely in clinical trials for substance use disorders.

Official title: MyTrials: An Integrated Tool to Support Remote Biomarker Capture within Decentralized Clinical Trials for Substance Use Disorders

Funded at Mountainpass Technology, LLC · NIH-11053714 · Data updated 2026-11-12

This study is testing a new tool called MyTrials that helps researchers collect important health samples from people with substance use disorders more easily and from home, making it simpler for everyone involved and hopefully leading to better treatment options for you.

More Substance Use research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMountainpass Technology, LLC
NIH-funded
Lab location1 site (Chevy Chase, United States)
Project startApril 15, 2025
Project endMarch 31, 2026
Funding year2025
Award (this year)$400,000
NIH project number1R42DA062250-01
Project IDNIH-11053714 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 21 and older who are participating in clinical trials for substance use disorders.

Less likely to help

Patients who are not involved in clinical trials or do not have substance use disorders may not receive any benefit from this research.

What this research studies

This research focuses on developing an integrated tool called MyTrials, which aims to facilitate the remote collection of biomarkers in decentralized clinical trials for individuals with substance use disorders. The tool addresses the challenges of existing biomarker capture methods that are primarily designed for clinical use rather than research. By enabling the simultaneous collection of multiple biospecimens, MyTrials seeks to streamline the process for researchers and improve the feasibility of conducting trials across various institutions. Patients will benefit from a more efficient trial process that can lead to better treatment options.

Why it matters

Potential benefit: If successful, this research could lead to more effective and streamlined clinical trials for substance use disorders, ultimately improving treatment outcomes for patients.

How similar studies have gone: Other research has shown promise in developing remote biomarker capture methods, but this integrated approach is relatively novel and aims to address specific challenges in substance use disorder trials.

Where this research is happening

  • Mountainpass Technology, LLC
    Chevy Chase, United States
    Active

Researchers

  • Principal investigator: Dahne, Jennifer Renee — Mountainpass Technology, LLC
  • Study coordinator: Dahne, Jennifer Renee

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.